FGF7 — Fibroblast Growth Factor 7

FGF7 — Fibroblast Growth Factor 7

Overview

FGF7 (Fibroblast Growth Factor 7), also known as keratinocyte growth factor (KGF), is a member of the fibroblast growth factor family that functions primarily as a paracrine growth factor[@finch1998]. Unlike other FGFs that bind multiple FGFR isoforms with high affinity, FGF7 exhibits specificity for FGFR2 (particularly the FGFR2-IIIb isoform) and FGFR1-IIIb, making it a targeted ligand for epithelial and certain neuronal cells[@bottaro2000].

Located on chromosome 19p13.3, the FGF7 gene encodes a 194-amino acid secreted protein with a molecular weight of approximately 26 kDa. The protein contains a typical FGF homology domain flanked by N-terminal and C-terminal regions that contribute to receptor specificity and heparin binding.

FGF7 is expressed in various tissues including skin, lung, gastrointestinal tract, and brain, where it plays critical roles in tissue repair, morphogenesis, and cellular survival. In the nervous system, FGF7 is produced by astrocytes and neurons, where it supports neural progenitor cell proliferation, neuronal survival, and synaptic function. Growing evidence links FGF7 to neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[@katsura2011].

Pathway / Interaction Diagram

FGF7 — Fibroblast Growth Factor 7

Overview

FGF7 (Fibroblast Growth Factor 7), also known as keratinocyte growth factor (KGF), is a member of the fibroblast growth factor family that functions primarily as a paracrine growth factor[@finch1998]. Unlike other FGFs that bind multiple FGFR isoforms with high affinity, FGF7 exhibits specificity for FGFR2 (particularly the FGFR2-IIIb isoform) and FGFR1-IIIb, making it a targeted ligand for epithelial and certain neuronal cells[@bottaro2000].

Located on chromosome 19p13.3, the FGF7 gene encodes a 194-amino acid secreted protein with a molecular weight of approximately 26 kDa. The protein contains a typical FGF homology domain flanked by N-terminal and C-terminal regions that contribute to receptor specificity and heparin binding.

FGF7 is expressed in various tissues including skin, lung, gastrointestinal tract, and brain, where it plays critical roles in tissue repair, morphogenesis, and cellular survival. In the nervous system, FGF7 is produced by astrocytes and neurons, where it supports neural progenitor cell proliferation, neuronal survival, and synaptic function. Growing evidence links FGF7 to neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[@katsura2011].

Pathway / Interaction Diagram

Gene Information

<div class="infobox infobox-gene">

| Property | Value |
|-----------|-------|
| Gene Symbol | FGF7 |
| Full Name | Fibroblast Growth Factor 7 |
| Alternative Names | KGF (Keratinocyte Growth Factor) |
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | [2254](https://www.ncbi.nlm.nih.gov/gene/2254) |
| Ensembl ID | [ENSG00000145681](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145681) |
| UniProt ID | [P21781](https://www.uniprot.org/uniprot/P21781) |
| OMIM | 148180 |
| Protein Type | Secreted growth factor |
| Molecular Weight | ~26 kDa |
| Associated Diseases | Alzheimer's disease, Parkinson's disease |

</div>

Normal Function

FGF7 Signaling Pathway

FGF7 signals through a restricted set of receptors[@bottaro2000]:

• FGFR2-IIIb (FGFR2b): Primary high-affinity receptor, epithelial-specific
• FGFR1-IIIb (FGFR1b): Lower affinity alternative

• RAS/MAPK pathway: Promotes cell proliferation and differentiation
• PI3K/AKT pathway: Mediates cell survival and anti-apoptotic effects
• PLCγ pathway: Regulates calcium signaling and cytoskeletal reorganization

• Epithelial growth and maintenance: Promotes epithelial cell proliferation and differentiation
• Tissue repair: Critical for wound healing through fibroblast migration and epithelialization
• Lung development: Essential for alveolar epithelial cell development
• Gastrointestinal function: Supports intestinal epithelial homeostasis
• Neuroprotection: Exhibits neurotrophic properties in the central nervous system

Brain Expression and Function

Expression Pattern

FGF7 is expressed in multiple tissues and in the brain:

• Hippocampus: Moderate expression in dentate gyrus and CA regions
• Cerebral cortex: Present in cortical neurons and glia
• Subventricular zone: Neural stem cells produce FGF7

• Astrocytes: Primary source of neuronal FGF7
• Neurons: Autocrine and paracrine signaling
• Oligodendrocyte progenitors: Support of myelination

Role in Neurodegeneration

Alzheimer's Disease

FGF7 is implicated in AD through multiple mechanisms[@kelley2012]:

Neuroprotection: FGF7 protects neurons against Aβ-induced toxicity through activation of FGFR2 and downstream signaling cascades involving PI3K/Akt and MAPK pathways.

Neural stem cell support: FGF7 promotes proliferation of neural stem cells in the subventricular zone and hippocampus, potentially supporting endogenous repair mechanisms.

Tau pathology interaction: FGF7 signaling may be affected by tau pathology, and conversely, FGF7 can modulate tau phosphorylation through GSK3β regulation[@park2020].

Synaptic function: FGF7 supports synaptic maintenance and plasticity, which are compromised in AD.

Parkinson's Disease

FGF7 contributes to PD through several mechanisms[@yamamoto2013]:

Dopaminergic neuron survival: FGF7 promotes survival of dopaminergic neurons in the substantia nigra, protecting against MPTP and 6-OHDA toxicity.

Neuroinflammation modulation: FGF7 can modulate microglial activation and reduce inflammatory responses that contribute to dopaminergic degeneration.

Neural regeneration: FGF7 supports migration and differentiation of neural progenitors that could replace lost neurons.

Neuroprotective Mechanisms

FGF7 protects neurons through[@katsura2011]:

• Upregulation of Bcl-2 family proteins
• Inhibition of caspase activation
• Preservation of mitochondrial integrity
• Reduction of oxidative stress

• Reduction of pro-inflammatory cytokine production
• Modulation of microglial activation states
• Protection of neurons from inflammatory damage

• Maintenance of dendritic spine density
• Preservation of synaptic protein expression
• Support of long-term potentiation

Therapeutic Strategies

Gene Therapy

FGF7 delivery represents a promising therapeutic approach[@ko2019]:

• AAV vectors: Effective delivery to brain parenchyma
• Protein delivery: Recombinant FGF7 can cross blood-brain barrier in some formulations

Biomarker Development

FGF7 as a biomarker[@yang2022]:

• CSF FGF7 levels: May correlate with disease progression
• Peripheral FGF7: Potential non-invasive marker

Interactions and Signaling Network

FGF7 interacts with multiple pathways:

| Pathway | Interaction | Function |
|---------|-------------|----------|
| FGFR2 | Direct binding | Primary signaling |
| Heparan sulfate | Required for signaling | Co-receptor |
| PI3K/Akt | Downstream pathway | Survival |
| MAPK/ERK | Downstream pathway | Proliferation |

FGF7 Signaling Cascade

FGF7 initiates signaling through a well-characterized cascade[@bottaro2000]:

The downstream signaling involves:

• RAS/RAF/MEK/ERK pathway: Controls cell proliferation and differentiation
• PI3K/AKT pathway: Mediates cell survival and anti-apoptotic signaling
• PLCγ pathway: Regulates calcium signaling and cytoskeletal reorganization

FGF7 in Neural Development

Developmental Expression

During neural development:

• FGF7 is expressed in the ventricular zone and subventricular zone
• Peak expression occurs during periods of active neurogenesis
• Astrocytes are the primary source of FGF7 in the developing brain

Neuronal Differentiation

FGF7 promotes neural progenitor cell proliferation and differentiation:

• Proliferation: FGFR2 signaling stimulates cell cycle progression
• Differentiation: Supports transition from progenitors to post-mitotic neurons
• Survival: Anti-apoptotic signaling protects developing neurons

FGF7 Receptor Expression in Brain

FGFR2 in Neurons

FGFR2 (particularly the IIIb isoform) is expressed in:

• Cortical neurons
• Hippocampal pyramidal cells
• Cerebellar Purkinje cells
• Substantia nigra dopaminergic neurons

FGFR1 Alternative

While FGF7 has lower affinity for FGFR1-IIIb, this receptor is more widely expressed and can mediate FGF7 effects in some neuronal populations.

Neuroprotective Mechanisms in Detail

Anti-Apoptotic Signaling

FGF7 protects neurons through multiple mechanisms[@katsura2011]:

Antioxidant Effects

FGF7 reduces oxidative stress:

• Upregulation of antioxidant enzymes (SOD, catalase, glutathione peroxidase)
• Reduction of lipid peroxidation
• Protection against ROS-induced damage

Anti-Inflammatory Actions

FGF7 modulates neuroinflammation[@wang2017]:

• Inhibition of microglial activation
• Reduced pro-inflammatory cytokine production (IL-1β, TNF-α, IL-6)
• Promotion of anti-inflammatory cytokine expression

Clinical Applications

Drug Development

Several therapeutic strategies are being developed:

• Recombinant FGF7 protein: For direct protein delivery
• Small molecule FGFR agonists: Brain-penetrant compounds
• Gene therapy vectors: AAV-mediated FGF7 expression

Research Applications

FGF7 is used in research to:

• Promote neuronal survival in culture
• Study FGFR signaling mechanisms
• Develop neuroprotective drug screens

FGF7 in Neural Development

Embryonic Neurogenesis

FGF7 plays essential roles during embryonic neural development:

Neural Plate Formation:

• FGF7 signaling influences early neural specification
• Regulates the transition from ectoderm to neural tissue
• Cooperates with other FGF family members in neural induction

• FGF7/FGFR2 signaling contributes to forebrain development
• Regulates patterning of the cerebral cortex
• Influences hippocampal formation

• FGF7 maintains neural progenitor cell populations
• Prevents premature neuronal differentiation
• Supports expansion of neural precursor pools

Postnatal Neurogenesis

In the adult brain, FGF7 continues to play important roles:

Subventricular Zone:

• FGF7 produced by astrocytes supports neural stem cells
• Promotes proliferation of transit-amplifying cells
• Regulates neuroblast migration to olfactory bulb

• FGF7 influences adult hippocampal neurogenesis
• Supports survival of newly generated neurons
• Regulates synaptic integration of new neurons

Gliogenesis

FGF7 also affects glial cell development:

Astrocyte Differentiation:

• FGF7 signaling promotes astrocyte lineage specification
• Regulates astrocyte proliferation and maturation
• Influences astrocyte morphological complexity

• FGF7 supports oligodendrocyte progenitor survival
• Regulates myelination processes
• Affects oligodendrocyte differentiation

FGF7 in Neuroinflammation

Microglial Modulation

FGF7 significantly affects microglial function:

Activation State Regulation:

• FGF7 can shift microglial polarization toward anti-inflammatory phenotype
• Reduces production of pro-inflammatory cytokines
• Promotes expression of anti-inflammatory mediators

• Modulates microglial phagocytosis of debris
• Affects clearance of apoptotic cells
• Regulates synaptic pruning processes

• Influences microglial migration patterns
• Controls microglial proliferation in response to injury
• Affects microglial recruitment to lesion sites

Astrocyte Reactivity

FGF7 modulates astrocyte responses to injury:

Reactive Astrocytosis:

• Regulates the magnitude of astrocyte reactivity
• Influences scar formation dynamics
• Affects expression of glial fibrillary acidic protein (GFAP)

• Promotes astrocyte secretion of neurotrophic factors
• Enhances astrocyte support of neuronal survival
• Modulates astrocyte metabolic support

FGF7 and Synaptic Plasticity

Long-Term Potentiation

FGF7 plays important roles in LTP:

Synaptic Strength:

• FGF7 signaling enhances synaptic transmission
• Promotes AMPA receptor trafficking to synapses
• Modulates NMDA receptor function

• FGFR2 activation leads to MAPK/ERK pathway activation
• PI3K/Akt signaling contributes to synaptic strengthening
• CREB-mediated gene transcription supports LTP maintenance

Long-Term Depression

FGF7 also affects LTD:

Synaptic Depression:

• Modulates AMPA receptor internalization
• Affects protein phosphatase activity
• Influences endocannabinoid signaling

Structural Plasticity

FGF7 supports structural changes at synapses:

Dendritic Spines:

• Promotes spine formation and maturation
• Regulates spine morphology
• Affects spine density changes during learning

• Modulates presynaptic terminal size
• Affects vesicle pool characteristics
• Influences active zone organization

Clinical Applications

Neurodegenerative Disease Therapy

FGF7 therapeutic approaches for neurodegenerative diseases:

Alzheimer's Disease:

• AAV-FGF7 delivery to hippocampus
• Combination with anti-amyloid therapies
• Targeting of neural stem cell niches

• FGF7 delivery to substantia nigra
• Protection of dopaminergic neurons
• Support of grafted cell survival

• Motor neuron protection
• Support of neuromuscular junction
• Modulation of glial responses

Delivery Strategies

Effective FGF7 delivery methods:

| Method | Advantages | Challenges |
|--------|------------|------------|
| AAV vectors | Long-term expression | Immune response |
| Protein injection | Direct delivery | Short half-life |
| Small molecules | Oral availability | Limited potency |
| Cell therapy | Site-specific | Manufacturing |

Biomarker Applications

FGF7 as a biomarker:

Diagnostic Markers:

• CSF FGF7 levels in neurodegenerative diseases
• Peripheral blood FGF7 measurements
• Correlation with disease severity

• Longitudinal changes in FGF7 expression
• Treatment response indicators
• Prognostic value in disease courses

FGF7 in Specific Brain Regions

Hippocampus

FGF7 functions in hippocampal circuits:

CA1 Region:

• Supports pyramidal neuron survival
• Modulates synaptic plasticity
• Affects memory consolidation

• Regulates neural stem cell activity
• Supports granule cell neurogenesis
• Influences pattern separation

Cortex

Cortical functions of FGF7:

Layer-Specific Effects:

• Different FGF7 responses across cortical layers
• Regulation of interneuron development
• Control of pyramidal neuron maturation

• Affects axonal projection development
• Modulates synapse formation
• Supports cortical circuit maturation

Cerebellum

FGF7 in cerebellar function:

Purkinje Cells:

• Supports Purkinje cell survival
• Regulates dendritic arborization
• Modulates synaptic plasticity

• Promotes granule cell development
• Affects migration patterns
• Supports inhibitory circuit formation

Molecular Signaling Networks

Downstream Effectors

FGF7 activates multiple signaling pathways:

RAS/MAPK Pathway:

• RAF → MEK → ERK cascade
• Controls cell proliferation and differentiation
• Regulates gene expression programs

• Promotes cell survival
• Inhibits apoptosis
• Supports metabolic functions

• Calcium signaling modulation
• Cytoskeletal reorganization
• Protein kinase C activation

Cross-Talk with Other Pathways

FGF7 interacts with numerous signaling networks:

Wnt/β-catenin:

• Synergistic effects on neural stem cells
• Shared target genes
• Cooperative neuroprotection

• Cross-regulation of differentiation
• Shared progenitor cell effects
• Opposing functions in some contexts

• Complementary effects on neurogenesis
• Coordinated patterning functions
• Combined therapeutic potential

Genetic and Pharmacological Modulation

Genetic Approaches

Modulating FGF7 expression:

Overexpression:

• AAV-mediated FGF7 gene delivery
• Inducible expression systems
• Cell-type specific promoters

• shRNA-mediated reduction
• CRISPR interference approaches
• Antisense oligonucleotide strategies

Pharmacological Modulators

Small molecule approaches:

FGFR Agonists:

• Recombinant FGF7 protein
• Small molecule FGFR2 activators
• Stabilized FGF7 variants

• FGFR blocking antibodies
• Tyrosine kinase inhibitors
• Decoy receptor approaches

Research Model Systems

In Vitro Models

| Model | Applications | Advantages |
|-------|--------------|------------|
| Primary neurons | Mechanism studies | Physiological |
| Neural stem cells | Proliferation | Expandable |
| Organoids | Development | 3D structure |
| iPSC neurons | Disease modeling | Patient-specific |

In Vivo Models

Mouse Models:

• FGF7 transgenic overexpression
• Conditional knockout systems
• Disease model crosses

• Live imaging capabilities
• Genetic tractability
• Developmental studies

• Translational relevance
• Complex brain functions
• Therapeutic testing

Therapeutic Development Pipeline

Preclinical Status

Current development stage:

• AAV-FGF7: Preclinical validation
• Recombinant protein: Formulation optimization
• Small molecules: Lead identification

Clinical Translation

Future clinical applications:

• Biomarker validation
• Dose-finding studies
• Patient selection criteria
• Combination therapy protocols

Future Research Directions

Unresolved Questions

Key questions in FGF7 research:

Emerging Approaches

New research directions:

• Engineered FGF7 variants with enhanced properties
• Cell-specific targeting strategies
• Biomarker development for patient selection
• Combination therapy protocols

See Also

• [FGF Signaling](/mechanisms/fgf-signaling)
• [FGFR2](/genes/fgfr2)
• [Neurotrophic Factors](/mechanisms/neurotrophic-factors)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neural Stem Cells](/cell-types/neural-stem-cells)
• [Neuroprotection](/treatments/neuroprotection)
• [Astrocytes](/cell-types/astrocytes)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving FGF7 — Fibroblast Growth Factor 7 discovered through SciDEX knowledge graph analysis: